SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
TUESDAY, July 30, 2019 -- Initiation of therapy with sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes mellitus is not associated with an increased risk for urinary tract infection (UTI) events compared with initiation of other...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Pharmaceuticals | Sodium | Urinary Tract Infections